Xenetic Biosciences, Inc.

NasdaqCM:XBIO Stok Raporu

Piyasa değeri: US$6.3m

Xenetic Biosciences Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Jim Parslow

İcra Kurulu Başkanı

US$433.7k

Toplam tazminat

CEO maaş yüzdesi75.9%
CEO görev süresi7.6yrs
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi5.7yrs

Son yönetim güncellemeleri

Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Dec 15
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Dec 01
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Recent updates

Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Dec 15
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable

Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Dec 01
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All

Xenetic Biosciences reports Q2 results

Aug 12

Xenetic Biosciences, VolitionRx collaborate to develop cell therapies to treat cancer

Aug 02

Xenetic inks clinical manufacturing contract with Catalent

Jul 07

Xenetic Biosciences reports Q3 results

Nov 13

CEO Tazminat Analizi

Jim Parslow'un ücretlendirmesi Xenetic Biosciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$434kUS$329k

-US$4m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$474kUS$329k

-US$7m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$521kUS$299k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$359kUS$285k

-US$11m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$388kUS$265k

-US$18m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$288kUS$265k

-US$7m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$960kUS$199k

-US$4m

Tazminat ve Piyasa: Jim 'nin toplam tazminatı ($USD 433.73K ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 655.02K ).

Tazminat ve Kazançlar: Jim 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Jim Parslow (59 yo)

7.6yrs

Görev süresi

US$433,732

Tazminat

Mr. James F. Parslow, also known as Jim, has been Chief Financial Officer at Xenetic Biosciences, Inc. since April 03, 2017 and serves as its Chief Operating Officer and Corporate Secretary and serves as i...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jeffrey Eisenberg
President & Director8.3yrsUS$563.49k0%
$ 0
Adam Logal
Independent Chairman of the Board7.3yrsUS$57.54k0%
$ 0
Roger Kornberg
Independent Director8.8yrsUS$57.54k0%
$ 0
Firdaus Dastoor
Independent Director10.8yrsUS$57.54k0%
$ 0
James Callaway
Independent Director7.3yrsUS$57.54k0%
$ 0
Dmitry Genkin
Non-Executive Directorless than a yearVeri yok4.44%
$ 280.7k
Guenther Koehne
Member of Scientific Advisory Board5.5yrsVeri yokVeri yok
Matthew Frigault
Member of Scientific Advisory Board5.8yrsVeri yokVeri yok
Alexey Vinogradov
Independent Director5.3yrsUS$57.54kVeri yok
Grigory Borisenko
Independent Non-Executive Director5.2yrsUS$57.54k0%
$ 0
Maksim Mamonkin
Member of Scientific Advisory Board4.8yrsVeri yokVeri yok
Allan Tsung
Member of Scientific Advisory Board2.5yrsVeri yokVeri yok

5.7yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: XBIO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.7 yıldır).